Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F71SS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,147
Award facts
- Contract value 100% obligated
- $14,146.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract valued at $14,146.97. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical contract enables AmerisourceBergen to supply pharmaceutical commodities globally to support customers including the Defense Health Agency and the U.S. Coast Guard. As a registered System for Award Management vendor, the company has consistently demonstrated its capability to meet federal procurement requirements through competitive bidding and maintains a substantial presence in the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F71SS?
SPE2DR26F71SS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26F71SS worth?
The government has obligated $14,147 on SPE2DR26F71SS.
Is contract SPE2DR26F71SS an order under another contract?
Yes. SPE2DR26F71SS is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F71SS competed?
The extent of competition for SPE2DR26F71SS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award